Phase III trial of high-dose sequential chemotherapy with peripheral blood stem cell support compared with standard dose chemotherapy for first-line treatment of advanced ovarian cancer: intergroup trial of the AGO-Ovar/AIO and EBMT.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples